SEC Form 3 · accession 0000899243-18-019669
Amneal Pharmaceuticals, Inc. · AMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dipan Patel
10% Owner
Period of report
Jul 5, 2018
Accepted (ET)
Jul 9, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001723128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | holding | — | — | — | 26,905,073 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common UnitsF1 | — | holding | — | — | — | — | — | Common Units | 26,905,073 | — | I |
Explanation of responses
- F1The Common Units may be redeemed at any time for shares of the Issuer's Class A Common Stock on a 1-to-1 basis.